Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Infection ; 48(3): 471-475, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32128685

RESUMEN

BACKGROUND: While Campylobacter jejuni represents the most common cause of bacterial gastroenteritis, Yersinia pseudotuberculosis infections are very rarely diagnosed in adults. CASE: We report on a previously healthy patient who presented several times at our hospital with fever, Guillain-Barré syndrome, recurrent abdominal symptoms and distinct mesenteric lymphadenopathy, respectively. This complicated and diagnostically challenging course of disease was caused by a C. jejuni and Y. pseudotuberculosis coinfection. Antibiotic treatment with doxycycline was effective. CONCLUSION: Broad serology testing was crucial to discover that two concomitant infections were causing the symptoms. This case demonstrates that when a clinical picture is not fully explained by one known infection, another infection with the same underlying risk factor has to be considered, hence "a horse and a zebra".


Asunto(s)
Infecciones por Campylobacter/diagnóstico , Coinfección/diagnóstico , Enfermedades Gastrointestinales/diagnóstico , Síndrome de Guillain-Barré/diagnóstico , Infecciones por Yersinia pseudotuberculosis/diagnóstico , Adulto , Antibacterianos/uso terapéutico , Infecciones por Campylobacter/diagnóstico por imagen , Infecciones por Campylobacter/tratamiento farmacológico , Infecciones por Campylobacter/microbiología , Campylobacter jejuni/aislamiento & purificación , Coinfección/diagnóstico por imagen , Coinfección/tratamiento farmacológico , Coinfección/microbiología , Doxiciclina/uso terapéutico , Fiebre/microbiología , Enfermedades Gastrointestinales/diagnóstico por imagen , Enfermedades Gastrointestinales/tratamiento farmacológico , Enfermedades Gastrointestinales/microbiología , Alemania , Síndrome de Guillain-Barré/diagnóstico por imagen , Síndrome de Guillain-Barré/microbiología , Humanos , Linfadenopatía/diagnóstico , Linfadenopatía/microbiología , Masculino , Recurrencia , Resultado del Tratamiento , Yersinia pseudotuberculosis/aislamiento & purificación , Infecciones por Yersinia pseudotuberculosis/diagnóstico por imagen , Infecciones por Yersinia pseudotuberculosis/tratamiento farmacológico , Infecciones por Yersinia pseudotuberculosis/microbiología
2.
Eur Radiol ; 27(6): 2657-2664, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27722798

RESUMEN

OBJECTIVES: To determine the detection rate of intracranial vessel occlusions using CT perfusion-based wavelet-transformed angiography (waveletCTA) in acute ischemic stroke patients, in whom single-phase CTA (spCTA) failed to detect an occlusion. METHODS: Subjects were selected from a cohort of 791 consecutive patients who underwent multiparametric CT including whole-brain CT perfusion. Inclusion criteria were (1) significant cerebral blood flow (CBF) deficit, (2) no evidence of vessel occlusion on spCTA and (3) follow-up-confirmed acute ischemic infarction. waveletCTA was independently analysed by two readers regarding presence and location of vessel occlusions. Logistic regression analysis was performed to identify predictors of waveletCTA-detected occlusions. RESULTS: Fifty-nine patients fulfilled the inclusion criteria. Overall, an occlusion was identified using waveletCTA in 31 (52.5 %) patients with negative spCTA. Out of 47 patients with middle cerebral artery infarction, 27 occlusions (57.4 %) were detected by waveletCTA, mainly located in the M2 (15) and M3 segments (8). The presence of waveletCTA-detected occlusions was associated with larger CBF deficit volumes (odds ratio (OR) = 1.335, p = 0.010) and shorter times from symptom onset (OR = 0.306, p = 0.041). CONCLUSIONS: waveletCTA is able to detect spCTA occult vessel occlusions in about half of acute ischemic stroke patients and may potentially identify more patients eligible for endovascular therapy. KEY POINTS: • waveletCTA is able to detect spCTA occult vessel occlusions in stroke patients. • waveletCTA-detected occlusions are associated with larger cerebral blood flow deficits. • waveletCTA has the potential to identify more patients eligible for endovascular therapy. • waveletCTA implies neither additional radiation exposure nor extra contrast agent.


Asunto(s)
Infarto de la Arteria Cerebral Media/diagnóstico , Infarto de la Arteria Cerebral Media/radioterapia , Accidente Cerebrovascular/etiología , Anciano , Encéfalo/irrigación sanguínea , Isquemia Encefálica/diagnóstico por imagen , Isquemia Encefálica/etiología , Angiografía Cerebral/métodos , Circulación Cerebrovascular/fisiología , Estudios de Cohortes , Angiografía por Tomografía Computarizada/métodos , Medios de Contraste , Femenino , Humanos , Infarto de la Arteria Cerebral Media/complicaciones , Masculino , Persona de Mediana Edad , Accidente Cerebrovascular/diagnóstico por imagen
3.
Crit Care ; 20(1): 312, 2016 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-27716447

RESUMEN

BACKGROUND: Acute bacterial meningitis is still a life threatening disease. METHODS: We performed a retrospective observational study on the clinical characteristics of consecutively admitted patients with acute pneumococcal meningitis in a single tertiary care center in central Europe (from 2003 until 2015). Data were compared with a previously published historical group of 87 patients treated for pneumococcal meningitis at the same hospital (from 1984 until 2002). RESULTS: Fifty-five consecutive patients with microbiologically proven pneumococcal meningitis were included. Most striking, mortality was down to 5.5 %, which was significantly lower than in the historical group where 24.1 % of the patients did not survive. Intracranial complications during the course of the disease were common and affected half of the patients. Unlike in the historic group, most of the intracranial complications (except ischemic stroke) were no longer associated with a low Glasgow Outcome Score at discharge. CONCLUSION: The drastic reduction of mortality proves there have been important advances in the treatment of pneumococcal meningitis. Nevertheless, the fact that only 44.2 % of survivors had a full recovery indicates that the search for new adjunctive treatment options must be ongoing.


Asunto(s)
Antibacterianos/farmacología , Meningitis Neumocócica/mortalidad , Esteroides/farmacología , Streptococcus pneumoniae/patogenicidad , Adulto , Anciano , Antibacterianos/uso terapéutico , Ceftriaxona/farmacología , Ceftriaxona/uso terapéutico , Dexametasona/farmacología , Dexametasona/uso terapéutico , Femenino , Alemania/epidemiología , Humanos , Masculino , Meningitis Neumocócica/epidemiología , Persona de Mediana Edad , Estudios Retrospectivos , Esteroides/uso terapéutico , Streptococcus pneumoniae/efectos de los fármacos
4.
Cureus ; 11(2): e4089, 2019 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-31032149

RESUMEN

Tumor necrosis factor-α (TNFα) plays a major role in inflammatory and vascular processes after cerebral ischemia. TNFa-Inhibitors have, on the one hand, been associated with thromboembolic events; on the other hand, they may prevent brain edema after stroke or injury. Here, we report on a 38-year old Caucasian male with a history of Crohn´s disease, treated with adalimumab, who presented without brain edema and only minor sequelae after a major ischemic stroke. This case report illustrates two interesting aspects: 1) the treatment with adalimumab could, in that case, be the etiology for the thromboembolic event; and (2) pretreatment with this TNFa-Inhibitor was the most likely reason why the formation of brain edema was suppressed.

5.
PLoS One ; 13(2): e0193051, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29466399

RESUMEN

INTRODUCTION: We investigated whether thrombus length measured in Computed Tomography Angiography (CTA) is predictive of the success rate of intravenous thrombolysis (IVT) in acute basilar occlusion and whether recanalization can be achieved by additional mechanical endovascular thrombectomy. METHODS: In 51 patients with acute basilar thrombosis thrombus length was measured on CTA images before intravenous thrombolysis (IVT) with rt-PA was started. After 114 minutes on average success of IVT was evaluated either by CTA or DSA. Patients with persistent basilar occlusion and no major brainstem infarction on CT underwent endovascular recanalization. RESULTS: 87% of patients had no recanalization of basilar artery after IVT alone. The average thrombus length was 15 mm in patients with persistent basilar occlusion after IVT and 7 mm in patients with recanalization after IVT. Thrombi longer than 13 mm did not resolve after IVT alone and 80% of thrombi shorter than 13 mm did not resolve either. 41 patients were transferred to endovascular recanalization; endovascular therapy was performed successfully in 90% (37 / 41). CONCLUSIONS: Recanalization rates in acute basilar occlusion after IVT alone are low and dependent on thrombus length. Additional mechanical endovascular thrombectomy showed to be a very successful recanalization therapy.


Asunto(s)
Arteria Basilar , Trombosis/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Arteria Basilar/diagnóstico por imagen , Angiografía por Tomografía Computarizada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Activadores Plasminogénicos/uso terapéutico , Estudios Retrospectivos , Terapia Trombolítica/métodos , Trombosis/diagnóstico por imagen , Trombosis/patología , Resultado del Tratamiento
6.
J Neurol ; 262(5): 1379-84, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25957640

RESUMEN

Aquaporin-4 antibody (AQP4-Ab)-positive neuromyelitis optica spectrum disorder (NMOSD) is a rare but often severe autoimmune disease with median onset around 40 years of age. We report characteristics of three very-late-onset NMOSD (including complete NMO) patients >75 years of age, in whom this diagnosis initially seemed unlikely because of their age and age-associated concomitant diseases, and briefly review the literature. All three patients, aged 79, 82 and 88 years, presented with a spinal cord syndrome as the first clinical manifestation of AQP4-Ab-positive NMOSD. They all had severe relapses unless immunosuppressive therapy was initiated, and one untreated patient died of a fatal NMOSD course. Two patients developed side effects of immunosuppression. We conclude that a first manifestation of NMOSD should be considered even in patients beyond the age of 75 years with a compatible syndrome, especially longitudinally extensive myelitis. Early diagnosis and treatment are feasible and highly relevant. Special attention is warranted in the elderly to recognize adverse effects of immunosuppressive therapies as early as possible.


Asunto(s)
Anticuerpos/sangre , Acuaporina 4/inmunología , Enfermedades de Inicio Tardío/sangre , Enfermedades de Inicio Tardío/diagnóstico , Neuromielitis Óptica/sangre , Neuromielitis Óptica/diagnóstico , Anciano , Anciano de 80 o más Años , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA